Nabsys Showcases Innovations in Genome Mapping at ASHG Meeting
Nabsys Showcases Innovations in Genome Mapping at ASHG Meeting
Nabsys 2.0, LLC, a leader in electronic genome mapping technology, is excited to present groundbreaking research at the highly anticipated American Society of Human Genetics (ASHG) Annual Meeting. The event is set to take place over several days, bringing together experts and innovators in the field of genomics. Their participation highlights the company's commitment to advancing genetic research.
This year, Nabsys will be hosting a special Google Colaboratory (Colab) Session in collaboration with Hitachi High-Tech America, Inc. and Boston Children's Hospital, showcasing their work in electronic genome mapping as part of a comprehensive strategy to address undiagnosed disorders. This session represents an opportunity for researchers to learn and engage in discussions about the latest advancements in genetic diagnostic technologies.
Overview of Presentations
The ASHG meeting is a prime venue for Nabsys to unveil eight presentations dedicated to various aspects of genome mapping. The company will display seven research posters along with the Colab session, emphasizing significant findings in the field. Here are the details of the presentations:
CoLab Session Details
Title: Electronic Genome Mapping as Part of a Comprehensive Multi-Omics Strategy for Undiagnosed Disorders
Presenter: Catherine Brownstein, M.P.H., Ph.D., Boston Children's Hospital
Date/Time: Wednesday, October 15, | 12:00 PM – 12:30 PM EDT
Location: Theater 1, Exhibit & Poster Hall/Lower Level
Notable Research Posters
Title: Accelerated Electronic Genome Mapping with Simultaneous Dual Nicking & Labeling: Boosting Structural Variant Calling on the OhmX Platform
Presenter: Jay Sage, Ph.D., Nabsys
Poster #: 4089W
Date/Time: Wednesday, October 15, | 2:30 PM – 4:30 PM EDT
Title: Electronic Genome Mapping as a Tool for Detection of TP53 Deletions in Genomic Analysis
Presenter: Yang Zhang, Ph.D., Nabsys
Poster #: 8028T
Date/Time: Thursday, October 16, | 2:30 PM – 4:30 PM EDT
Title: Electronic Genome Mapping for High-Throughput Analysis of Repeat Expansion Disorders
Presenter: Syndi Koltz, Ph.D., Nabsys
Poster #: 4065T
Date/Time: Thursday, October 16, | 2:30 PM – 4:30 PM EDT
Title: Improving Electronic Genome Mapping Coverage With CRISPR/Cas9
Presenter: Lindsay Schneider, Ph.D., Nabsys
Poster #: 4068T
Date/Time: Thursday, October 16, | 2:30 PM – 4:30 PM EDT
Title: Comprehensive Multi-Omics Study of Interstitial Cystitis/Bladder Pain Syndrome
Presenter: Elicia A. Estrella, M.S., LCGC, Boston Children's Hospital
Poster #: 4101T
Date/Time: Thursday, October 16, | 2:30 PM – 4:30 PM EDT
Title: Electronic Genome Mapping of Somatic Structural Variants
Presenter: John Thompson, Ph.D., Nabsys
Poster #: 9031F
Date/Time: Friday, October 17, | 2:30 PM – 4:30 PM EDT
Title: Development of a Classification Model for Predicting Structural Polymorphism of EGM-Detected Variants in the Human Genome
Presenter: Sachiho Abe, M.S., Hitachi High-Tech America, Inc.
Poster #: 5078F
Date/Time: Friday, October 17, | 2:30 PM – 4:30 PM EDT
Significance of the Event
Participating in the ASHG Annual Meeting is pivotal for Nabsys, allowing the company to network with other leaders and research professionals in the field. The shared knowledge and expertise among the attendees are crucial for tackling ongoing challenges in genomics. Nabsys aims to contribute to these discussions while enhancing its visibility in the evolving landscape of genomic research.
Each presentation will be available post-event on the company’s website, providing an opportunity for broader access to the insights shared during the meeting.
About Nabsys 2.0, LLC
Nabsys is dedicated to improving the understanding of diseases through cutting-edge genomic research. Their goal is to provide accurate and cost-effective analysis of genomic structural variation. Located in Rhode Island, their team consists of a diverse group of professionals, all committed to pushing the boundaries of genomic analysis.
Frequently Asked Questions
What is Nabsys known for?
Nabsys is known for its innovative electronic genome mapping technology aimed at enhancing genetic research and diagnostics.
Where is the ASHG Annual Meeting taking place?
The ASHG Annual Meeting will be held in Boston, bringing together experts in the field of human genetics.
What presentations will Nabsys be showcasing?
Nabsys will showcase multiple presentations, including research on electronic genome mapping and its applications in various genetic disorders.
Who will be presenting at the Nabsys sessions?
Presentations will feature experts such as Catherine Brownstein, Jay Sage, and other notable researchers associated with Nabsys and collaboration partners.
How can I access the presentations after the event?
Post-event presentations will be available on Nabsys’ website in the Resources section, allowing greater access to the information presented.
About The Author
Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
